213 related articles for article (PubMed ID: 2567994)
1. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.
Pearce HL; Safa AR; Bach NJ; Winter MA; Cirtain MC; Beck WT
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5128-32. PubMed ID: 2567994
[TBL] [Abstract][Full Text] [Related]
2. Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance.
Pearce HL; Winter MA; Beck WT
Adv Enzyme Regul; 1990; 30():357-73. PubMed ID: 1976291
[TBL] [Abstract][Full Text] [Related]
3. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
5. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
6. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
Bhat UG; Winter MA; Pearce HL; Beck WT
Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
[TBL] [Abstract][Full Text] [Related]
7. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
9. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoprotein.
Granzen B; Graves DE; Baguley BC; Danks MK; Beck WT
Oncol Res; 1992; 4(11-12):489-96. PubMed ID: 1363724
[TBL] [Abstract][Full Text] [Related]
11. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.
Nogae I; Kohno K; Kikuchi J; Kuwano M; Akiyama S; Kiue A; Suzuki K; Yoshida Y; Cornwell MM; Pastan I
Biochem Pharmacol; 1989 Feb; 38(3):519-27. PubMed ID: 2563655
[TBL] [Abstract][Full Text] [Related]
12. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
13. New triazine derivatives as potent modulators of multidrug resistance.
Dhainaut A; Régnier G; Atassi G; Pierré A; Léonce S; Kraus-Berthier L; Prost JF
J Med Chem; 1992 Jun; 35(13):2481-96. PubMed ID: 1352353
[TBL] [Abstract][Full Text] [Related]
14. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.
Tang-Wai DF; Brossi A; Arnold LD; Gros P
Biochemistry; 1993 Jun; 32(25):6470-6. PubMed ID: 8100149
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity.
Mayur YC; Padma T; Parimala BH; Chandramouli KH; Jagadeesh S; Gowda NM; Thimmaiah KN
Med Chem; 2006 Jan; 2(1):63-77. PubMed ID: 16787357
[TBL] [Abstract][Full Text] [Related]
16. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
Zamora JM; Pearce HL; Beck WT
Mol Pharmacol; 1988 Apr; 33(4):454-62. PubMed ID: 3162758
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic circumvention of multidrug resistance.
Ford JM; Hait WN
Cytotechnology; 1993; 12(1-3):171-212. PubMed ID: 7765325
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine.
Safa AR; Mehta ND; Agresti M
Biochem Biophys Res Commun; 1989 Aug; 162(3):1402-8. PubMed ID: 2569869
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
20. Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance.
Hait WN; Aftab DT
Biochem Pharmacol; 1992 Jan; 43(1):103-7. PubMed ID: 1346493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
